Japan

Asia drives critical innovation for the region and the world

Innovation is more important than ever in today’s fast-changing world, and Asia’s place in the global innovation ecosystem has never been more critical. A new report  from Clarivate explores Asia’s IP landscape across domains, trademarks and patents. Intellectual property (IP) research and protection play an essential role in accelerating the pace of innovation. IP allows […]

Standing together while apart: Clarivate APAC faces the pandemic as one team

A virus knows no boundaries. In less than four months, the novel coronavirus has spread to all continents except Antarctica, earning the classification of pandemic from the World Health Organization and surpassing 1.7m cases globally (as of April 12). As the virus continues to spread around the world, the news and facts surrounding it continue […]

Early HTA developments in Japan offer some positives for the pharma industry

The Japanese pharmaceutical market has been an ideal environment for the industry thanks to minimal regulatory delays, favorable pricing and high reimbursement rates. In the near future, however, this market is poised to become more restrictive as the Japanese government feels the pressure of financing its healthcare system amid a rapidly aging population. With many […]

Market Access Challenges in 2017: Impacts of Japan’s Drug Pricing Policy Reforms

Authorities have witnessed a surge in healthcare expenditure in recent years in Japan, where costs of prescription drugs are reimbursed by the government under the Public Health Insurance System (PHIS). For the 2015 fiscal year, the MHLW reported a 3.8% increase in overall medical expenditure, which reached JPY41.46 trillion (US$340 billion) compared to JPY 39.96 […]